Sign in

Li Wenwen

Research Analyst at Danasting

Li Wenwen is an equity analyst at Danasting, specializing in coverage of major Chinese technology and consumer companies. She tracks and provides research on firms such as Alibaba, Tencent, JD.com, and Pinduoduo, earning recognition for her timely investment insights and accurate financial forecasts. Since joining Danasting in 2021 after previous roles at CITIC Securities, Li has achieved a documented success rate of over 64% on stock recommendations and consistently ranks in the top quartile of Chinese market research analysts by third-party platforms. Li holds the CFA designation and is registered with FINRA, bringing deep quantitative analysis skills and sector expertise to her research coverage.

Li Wenwen's questions to Viatris (VTRS) leadership

Question · Q3 2025

Li Wenwen asked about Viatris's confidence in the sales ramp and peak sales potential for fast-acting meloxicam, and if there were any lessons learned from competitor JornoVix's slow launch.

Answer

CEO Scott Smith expressed strong excitement for meloxicam, citing data and team expertise, estimating peak sales in the $500 million range, with more clarity in 2026. He emphasized plans to commercialize it as a branded product, expecting it to be a meaningful contributor for at least the rest of the decade, with active efforts to expand its IP and exclusivity.

Ask follow-up questions

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%